Jefferies Financial Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Sell |
53,200
-28,113
| -35% | -$886K | 0.01% | 408 |
|
|
2025
Q1 | $2.66M | Buy |
81,313
+56,713
| +231% | +$1.86M | 0.02% | 359 |
|
|
2024
Q4 | $890K | Buy |
+24,600
| New | +$890K | 0.01% | 693 |
|
|
2024
Q1 | – | Sell |
-35,108
| Closed | -$1.02M | – | 1524 |
|
|
2023
Q4 | $1.02M | Buy |
+35,108
| New | +$1.02M | 0.01% | 632 |
|
|
2023
Q3 | – | Sell |
-53,200
| Closed | -$1.6M | – | 1417 |
|
|
2023
Q2 | $1.6M | Sell |
53,200
-35,500
| -40% | -$1.07M | 0.01% | 450 |
|
|
2023
Q1 | $3.21M | Buy |
+88,700
| New | +$3.21M | 0.03% | 279 |
|